Teleflex TFX
NYSE · Surgical & Medical Instruments & Apparatus · $7.0BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $2.8B | $2.8B | $1.7B | $1.7B | $2.0B | +17.2% | −8.2% | |
| Cost of Revenue (COGS) | $1.3B | $1.3B | $672.3M | $662.2M | $872.0M | +31.7% | −8.8% | |
| Gross Profit | $1.5B | $1.5B | $1.0B | $1.0B | $1.1B | +8.0% | −7.8% | |
| Research & Development (R&D) | $130.8M | $153.8M | $113.6M | $109.0M | $144.8M | +32.8% | +2.6% | |
| Selling, General & Admin (SG&A) | $860.1M | $863.7M | $622.7M | $674.5M | $720.2M | +6.8% | −4.3% | |
| Total Operating Expenses | $921.5M | $1.0B | $781.4M | $933.7M | $1.0B | +7.4% | +2.1% | |
| Operating Income (EBIT) | $628.1M | $499.7M | $258.7M | $103.7M | $118.4M | +14.2% | −34.1% | |
| Interest Expense | $57.0M | $54.3M | $85.1M | $83.5M | $100.2M | +20.0% | +15.2% | |
| Income Tax Expense | $74.3M | $83.0M | $41.9M | $-30.9M | $-34.0M | −10.0% | — | |
| GAAP Net Income | $485.4M | $363.1M | $357.6M | $70.2M | $-905.6M | −1390.8% | — | |
| Diluted EPS | $10.23 | $7.68 | $7.53 | $1.48 | $-20.25 | −1468.2% | — | |
| Diluted Shares | 47.4M | 47.3M | 47.3M | 47.1M | 44.7M | −5.0% | −1.5% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $445.1M | $292.0M | $222.8M | $327.6M | $402.7M | +22.9% | −2.5% | |
| Inventory | $477.6M | $578.5M | $626.2M | $306.8M | $404.4M | +31.8% | −4.1% | |
| Total Current Assets | $1.4B | $1.4B | $1.4B | $1.5B | $1.9B | +31.8% | +7.9% | |
| Total Assets | $6.9B | $6.9B | $7.5B | $7.1B | $6.9B | −2.1% | +0.3% | |
| Total Current Liabilities | $680.1M | $581.5M | $606.7M | $649.4M | $762.0M | +17.4% | +2.9% | |
| Total Debt (Short + Long Term) | $2.0B | $1.8B | $1.9B | $1.8B | $2.7B | +56.1% | +8.7% | |
| Total Liabilities | $3.1B | $2.9B | $3.1B | $2.8B | $3.8B | +35.6% | +5.2% | |
| Stockholders' Equity | $3.8B | $4.0B | $4.4B | $4.3B | $3.1B | −27.0% | −4.5% | |
| Net Cash / (Net Debt) | $-1.5B | $-1.5B | $-1.7B | $-1.4B | $-2.3B | −63.8% | — | |
| Invested Capital | $5.3B | $5.5B | $6.1B | $5.7B | $5.5B | −4.3% | +0.9% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $652.1M | $342.8M | $206.1M | $301.9M | $96.7M | −68.0% | −37.9% | |
| Depreciation & Amortization (D&A) | $237.4M | $230.6M | $148.1M | $161.5M | $177.7M | +10.0% | −7.0% | |
| Stock-Based Compensation (SBC) | $22.9M | $27.2M | $27.3M | $26.0M | $25.7M | −1.0% | +2.9% | |
| Capital Expenditures (CapEx) | $71.6M | $79.2M | $46.4M | $90.4M | $95.2M | +5.3% | +7.4% | |
| Free Cash Flow (FCF) | $580.5M | $263.6M | $159.7M | $211.4M | $1.4M | −99.3% | −77.7% | |
| True FCF (ex-SBC Owner Cash) | $557.6M | $236.4M | $132.4M | $185.5M | $-24.2M | −113.1% | — | |
| Share Repurchases (Buybacks) | — | $0 | $0 | $200.0M | $300.0M | +50.0% | — | |
| Dividends Paid | $63.6M | $63.8M | $63.9M | $63.5M | $60.3M | −5.2% | −1.4% | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.